SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 116 filers reported holding SANA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $406,021 | -34.2% | 104,915 | +1.3% | 0.00% | – |
| Q2 2023 | $617,050 | +76.5% | 103,532 | -3.2% | 0.00% | – |
| Q1 2023 | $349,569 | +131.5% | 106,902 | +179.7% | 0.00% | – |
| Q4 2022 | $150,997 | -34.6% | 38,227 | -0.6% | 0.00% | – |
| Q3 2022 | $231,000 | -95.2% | 38,454 | -94.9% | 0.00% | -100.0% |
| Q2 2022 | $4,824,000 | +1471.3% | 750,198 | +1917.0% | 0.00% | – |
| Q1 2022 | $307,000 | -44.8% | 37,193 | +3.6% | 0.00% | – |
| Q4 2021 | $556,000 | -16.9% | 35,913 | +20.8% | 0.00% | – |
| Q3 2021 | $669,000 | -18.8% | 29,729 | +20.7% | 0.00% | – |
| Q1 2021 | $824,000 | – | 24,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
| Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
| Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
| Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
| Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
| SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
| HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
| Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
| Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |